Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  London Stock Exchange  >  Puretech Health PLC    PRTC   GB00BY2Z0H74

PURETECH HEALTH PLC (PRTC)
Mes dernières consult.
Most popular
Rapport
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Summary
  • In view of fundamental criteria, the company is among low performers as far as mid or long-term investment strategy is concerned.
  • For a short-term investment strategy, the company has poor fundamentals.
Strengths
  • The current area is a good opportunity for investors interested in buying the stock in a mid or long-term perspective. Indeed, the share is moving closer to its lower bound at GBp 125 GBp in weekly data.
  • Share prices are approaching a strong support area in daily data, which offers good timing for investors.
  • Growth remains a strong point in this company. In their sales forecast, analysts sound optimistic with regard to sales prospects.
  • Over the past year, analysts have regularly revised upwards their sales forecast for the company.
  • Analysts covering this company mostly recommend stock overweighting or purchase.
  • The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
  • Within the weekly time frame the stock shows a bullish technical configuration above the support level at 125 GBp
Weaknesses
  • As estimated by analysts, this group is among those businesses with the lowest growth prospects.
  • The company has insufficient levels of profitability.
  • One of the major weak points of the company is its financial situation.
  • Sales estimates for the next fiscal years vary from one analyst to another. This clearly highlights a lack of visibility into the company's future activity.
  • The company's "enterprise value to sales" ratio is among the highest in the world.
Ratings chart
Sector Biotechnology & Medical Research - NEC
1st jan.Capitalisation (M$)Investor Rating
PURETECH HEALTH PLC8.59%401
INCYTE CORPORATION14.83%24 254
QUINTILES IMS HOLDINGS INC32.72%21 711
CELLTRION, INC.--.--%20 802
LONZA GROUP59.82%19 730
ALNYLAM PHARMACEUTICALS, IN..213.97%10 783
SEATTLE GENETICS, INC.20.67%9 108
IONIS PHARMACEUTICALS INC33.58%7 945
QIAGEN NV18.22%7 941
ALKERMES PLC-8.08%7 850
ICON PLC52.25%6 187
INC RESEARCH HOLDINGS INC3.99%5 663
EXACT SCIENCES CORPORATION248.95%5 552
CHARLES RIVER LABORATORIES ..50.54%5 459
UNITED THERAPEUTICS CORPORA..-16.25%5 218
PRA HEALTH SCIENCES INC49.49%5 162
More Results
Financials ($)
Sales 2017 1,63 M
EBIT 2017 -120 M
Net income 2017 -97,2 M
Finance 2017 171 M
Yield 2017 -
P/E ratio 2017 -
P/E ratio 2018
EV / Sales 2017 141x
EV / Sales 2018 102x
Capitalization 401 M
Surperformance© ratings
  Help  
Fundamental ratings
Overall rating
Trading Rating
Investor Rating
Growth (Revenue)
Valuation
Finances
Profitability
Earnings quality
Business Predictability
P/E ratio -
Potential
Yield -
Consensus
7 days EPS revision
4 months EPS revision -
1 year EPS revision
4 months Revenue revision
1 year Revenue revision
Technical ratings
Short Term Timing
Middle Term Timing
Long Term Timing
RSI
Bollinger Spread
Unusual Volumes
Chart PURETECH HEALTH PLC
Duration : Period : Day
Puretech Health PLC Technical Analysis Chart | PRTC | GB00BY2Z0H74 | 4-Traders
Duration : Period : Week
Puretech Health PLC Technical Analysis Chart | PRTC | GB00BY2Z0H74 | 4-Traders